Yahoo Finance Momentum investing with Minerva Neurosciences Inc (NMQ:NERV)
Intriguing research into stock market price trends shows that investors behave strangely when a stock trades close to its 52-week high...
Despite flying high, holders of the shares are more likely to sell out and snatch a profit than hold on for the ride. And for anyone standing on the sidelines, a new-high feels like they've already missed out.
But both are wrong.
In fact, stocks with strong price trends are statistically more likely to benefit from continuing momentum. It may not feel like it, but these kinds of trends tend to persist.
With this in mind, shares in Minerva Neurosciences Inc (NMQ:NERV) have been in an uptrend in recent months, with strong relative price strength against the market. Here's what we've seen...
GET MORE DATA-DRIVEN INSIGHTS INTO NMQ:NERV »
Minerva Neurosciences Inc (NMQ:NERV)'s relative price strength
Minerva Neurosciences Inc operates in the Biotechnology & Medical Research industry and in terms of relative price strength the stock has performed well against the market over the past year:
1 Month: 99.8%
6 Months: 157.4%
12 Months: 155.8%
Relative strength is a useful tool in the armoury of technical traders and investors. It’s an instant measure of how a stock has performed in comparison with a benchmark.
And while there are no certainties about which way a stock will move next, research shows that those with the strongest price strength tend to keep up the pace for anywhere up to one year as investors increasingly buy in to them.
Finding shares with a given relative price against your local share index is best done with a screening tool, which helps you discover shares you may have never heard of.
Next steps
Minerva Neurosciences Inc is currently among the stocks with the strongest six-month and one-year relative price strength in the market. A look at its StockReport could offer more insight into what’s driving the momentum in its share price - and whether that might continue.
To find more stocks like Minerva Neurosciences Inc, you'll need to equip yourself with professional-grade data and screening tools. This kind of information has traditionally been closely guarded by professional fund managers. But our team of financial analysts have carefully constructed this screen - Stockopedia’s Price Momentum - which gives you everything you need. So why not come and take a look?
